by Jordana Choucair | Oct 20, 2022 | Life Sciences
An FDA advisory panel recommended to pull Makena, a pre-term birth prevention drug, off the market. The panel said that the drug has not shown to be effective and exposes women to “serious risk.” The decision came after years of tension between the company, the...
by Jordana Choucair | Oct 20, 2022 | Payers
Surgeon General Vivek Murthy released guidance detailing how long hours, lack of autonomy, low pay, and other elements of a toxic workplace can impact the health and organizational performance of workers. The guidance supports the Surgeon General’s Advisory on...
by Jordana Choucair | Oct 19, 2022 | D.C. News
The White House released a memorandum to protect the U.S. from future pandemics and biological threats. The memorandum outlines a strategy aimed at detecting early warnings of pandemics and biological threats, preventing epidemics and biological incidents, and...
by Jordana Choucair | Oct 19, 2022 | Inequities and SDOH
A study in Circulation: Heart Failure found that Black patients were less likely to receive heart failure care, even when they had access, adequate insurance coverage, and an expressed desire to get treatment. Researchers studied 377 patients receiving treatment for...
by Jordana Choucair | Oct 19, 2022 | Life Sciences
The Kaiser Family Foundation released a brief examining how accessibility and cost of COVID-19 vaccines, treatments, and tests will change after the public health emergency (PHE) ends and such countermeasure efforts shift to the commercial market. The brief points out...
by Jordana Choucair | Oct 19, 2022 | Mental Health
U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra announced that hundreds of millions of dollars will be awarded to support Certified Community Behavioral Health Clinics (CCBHCs). The federal government is offering $1 million grants next year...
Recent Comments